Safesea Group: A single point Solution for All Logistics Needs

The Indian logistics sector is on a big growth tide. The country’s logistics industry which is worth around USD 160 billion is likely to touch USD 215 billion in the next two years with the implementation of GST, according to the Economic Survey. With the implementation of GST, the Indian logistics market is expected to reach about USD 215 billion in 2020, growing at a CAGR of 10.5 per cent. The Indian logistics industry which provides employment to more than 22 million people has grown at a compound annual growth rate (CAGR) of 7.8 per cent during the last five years.

The Global Ranking of the World Bank’s 2016 Logistics Performance Index shows that India jumped to 35th rank in 2016 from 54th rank in 2014 , in terms of overall logistics performance. The report also showed that India’s logistics sector has improved its performance on all the six parameters used in the ranking. This is a huge jump of 20 ranks and clearly indicates the growth of the sector. Understanding the future prospect of the Indian Logistic market an international shipping conglomerate, the Safesea Group, of shipping and logistics voyage was established to take the logistic industry to the next level. This global entity was conceptualized, formed and steered by the vision and passion of a thorough shipping professional, S V Anchan, a third generation in this domain. “Journey of Passion always has its own pleasure. As this is not a business for us, but passion, where Shipping happens to be our religion. It was during the year 2008 (recession period), we took a bold decision to establish a new company for catering to specialized cargoes like project shipments, Break Bulk and Bulk shipments.”

A flexible & innovative logistics solution

Headquartered in New Jersey, USA, Safesea caters to a multiple array of high quality professional services such as shipping & chartering; which includes Oil Tankers i.e Crude Tankers carrying large quantities of unrefined crude oil from point of extraction to refineries of 300,000MT. Product Tankers are designed to carry refined products from refineries to regions with a consumer base. Products include gasoil, naptha, aviation fuel, gasoline and many more. Chemical specialized Tankers commonly known as parcel tankers, team Safesea carefully yet aggressively scouts for opportunities to load full or part cargoes based on regional pricing and global demand.

Logistic & Transportation service are such as Ocean & Air Freight an enviable service provider with high performance standards flexibility to meet the changing needs of the industry. This  includes Visibility and Control, Global Access to Expand Horizons and Tracking on-time delivery solutions. Warehousing/Custom Clearance are among the broad array of services available across our offices worldwide.

“Our passion has existed for three generations and will flow until the ocean world prevails. We offer one window service under one roof for all the shipping needs, as we move anything that needs to be moved. We are empaneled with various local and international bodies & organizations. Thru our global offices we offer 24 x 7 services,” said S V Anchan, Founder, Safesea.

Elongating the Parameters to go an Extra Mile

An ISO 9001:2015 certified company Safesea has a wide range of patrons  ,  Catered to the requirements of Indian Oil, 3M, Siemens, Alpine, NTPC, ISO, Essar, , Mena Energy are to name a few. “The Conviction, Passion and Shipping did not deter from working like an extension of our clients, which gave us the opportunity to understand the need of our valued clients more closely with a personal touch. This enhanced bond and personalized service with our clients gave us the opening to share & provide tailor made solutions. We provided consultancy services at no cost which eventually unlocked the doors for ancillary services like warehousing & distribution, project managements and Military cargoes. However we still believe in what is called people interaction instead of making the digital technology to respond to customer’s queries. Since shipping is a Stone Age biz, somehow I personally feel the interaction and relationship plays a pivotal role and is name of the game of our biz. Though we have advanced technology in place, but as far as customer interaction is concerned we still manage through live interaction. We firmly believe on the phrase that “Don’t Go where the PATH may LEAD, Go instead where there is no path and leave TRAILs”. This helped us to retain our clients in all weather,” added S V Anchan.

The journey so far

Established over a decade ago, Safesea has come a long way from where it all started. Owing to consistent commitment to value-based business, Safesea has witnessed robust growth leading to an expansion of its presence on a global scale. The group is headquartered in USA, having offices in Canada, Denmark, United Kingdom, India & Bangladesh (South Asia) UAE & Iraq (Middle Est) and Singapore (South East Asia), along with a network of allied offices in over 100 countries.

The Logistic firm has bagged many awards and recognition due to its tireless hard work. Some of the famous award and recognition received by Safesea group are as follows:

  • Future 50 fastest growing companies Award 2015 by SmartCEO
  • Bulk Logistics Excellence Award 2015 for diversified interest within shipping verticals by IBJ, UK
  • International Leadership Innovation Excellence AWARD & Gold Medal by Institute of Economic Studies 2017
  • Mahatma Gandhi Sanman Award by House of Lords, UK 2017
  • Maritime Excellence AWARD 2017 by Govt. Of Telangana State and Indy wood

The Force behind the Accomplishment

The stiff and the rigid team of Safesea is the pillar behind the company’s execution. The simple and uncomplicated policy of the organization doesn’t box the employee, but gives them a transparent atmosphere with free flow of knowledge without firewall. Cross department trainings are given to the employees to make them a holistic shipping professionals. There is no thick wall between the department likewise  the employees. This mitigates the red tape, which helps in achieving quick turn around and better output. As the firm believes that the growth of the employees will lead to the growth of the company.

In Pursuit of Serving Clients Better

S V Anchan is the master mind behind the dazzling success of the Safesea Group. He is instrumental in the meteoric rise and success of this enterprise, which has expanded its footprints across the globe over the past decade. Under Mr. Anchan’s leadership, Safesea Group became one of the few shipping firms over the world that caters to a wide & deep array of high quality professional services.

The self-proclaimed ‘old-fashioned’ yet extremely ‘courageous’ S V Anchan is the perfect combination of inspiration and passion. That’s because he has earned his name as one of the most renowned businessmen across the globe and continues to expand his footprint. Sheer dedication, in-depth knowledge and accurate market analysis makes him the businessman that he is today. The Safesea Group has drastically gained recognition and accolades over a little more than a decade and still counting owing to his expertise and innovative ideas.

Some of the biggest achievements of S V Anchan’s are:

  • The first and only Indian-origin American to own ships in North America
  • Best Ship Operator of the Year Finalist by Lloyds, UK, 2017
  • International Man of the Year at the 7th Annual Congressional AWARD, USA, 2017
  • Winner of the Global Indian Icon AWARD by Stardust in New York, 2017
  • Finalist of Lloyd’s List Dry Bulk Operator of the Year Maritime Award, 2017
  • International Leadership Innovation Excellence AWARD & Gold Medal by Institute of Economic Studies, 2017
  • ETNOW Stars of the Industry – Most Innovative Leader AWARD, 2018
  • The only Indian-American shipping professional to own offices in USA, Canada, United Kingdom, Denmark, India, Iraq, Dubai, Bangladesh and Singapore
  • He was the first shipping professional to land in Iraq in 1997 post the Iraq-Kuwait war to offer shipping services under United Nations’ Oil for Food Program

The Future Roadmap

The company with a positive outlook aspires to double its revenue and clients in the year to come. “Our determination to grow the business with a purpose started with a SWOT analysis to accomplish our “VISION 2020”, from which we conceived our development and execution strategies which includes Developing a strategic direction, supported by necessary allocation of resources and coordinated business unit plans and Execution by analyzing the structure and dynamics of each of the relevant markets and allocation of resources, along with asset procurement, we anticipate a greater return on investments,” concluded Anchan.

Alniche Life Sciences: A Journey of Passion, Brilliance & Success

Healthcare has become one of India’s largest sectors both in terms of revenue and employment. The Indian healthcare sector is growing at a brisk pace due to its strengthening coverage, services and increasing expenditure by public as well private players. The healthcare market can increase three fold to Rs 8.6 trillion by 2022. India is experiencing 22-25 % growth in medical tourism and the industry is expected to reach US$ 9 billion by 2020. There is a significant scope for enhancing healthcare services considering that healthcare spending as a percentage of Gross Domestic Product (GDP) is rising. The government’s expenditure on the health sector has grown to 1.4 % in FY18E from 1.2 % in FY14. The Government of India is planning to increase public healthcare spending to 2.5 % of the country’s GDP by 2025.

Alniche Life Sciences is a specialty healthcare company focused on discovering, developing and commercializing innovative pharmaceuticals products enabling people to live life with greatest potential to see more clearly, move more freely and express themselves more fully. Alniche Life Sciences serves patients and the medical fraternity by offering specialized, high-quality, effective, affordable medicines and wellness products from all around the world. In a rather short period of about a decade, Alniche has carved a firm position for itself in the Indian Pharma market through a focussed approach for key brands and deep engagement with doctors. Its strong portfolio, with products both domestic & licensed from global partners, fulfils the unmet needs of patients in the areas of nephrology, critical care, gastroenterology, dermatology, and advanced wound care. Further the firm also lay emphasise on Renal Care, Critical care, Skinceuticals, Gastroenterology, Advanced Wound Care and Neurology. “Our focus promotes deep engagement with medical specialists and we make it our business to listen to them closely, together we advance in patient care. We combine this strategic focus with a diversified approach that enables us to follow our new specialty areas where unmet needs are significant,” says Girish Arora, Founder, Alniche Life Science.

Bringing Deep and Varied know-how of Wellness

Girish Arora, the founder & managing director of the company, reflecting on the journey of Alniche says, “It all started ten years ago, when after 25 years of experience of heading niche therapy areas in India in various renowned companies, I felt the void for a Nephrology focussed organization covering all Nephrologists across India. Till then most of the organizations had Nephrology as a division with divided focus on this therapy segment. I was convinced that the specialists and patients in
this segment needed greater attention and this conviction was the driving force behind inception of Alniche.”

From a humble beginning of field strength of 50, the company has now expanded to more than 700 and carefully diversified from Nephrology to synergistic segments of Critical care, Gastroenterology, Skinceuticals and now Advanced Woundcare and now Neurology. What started as a modest business venture, Alniche has emerged as a fierce competitor in Nephrology and Critical Care segment and continuing the success story in newly expanded therapy segments. The company is ranked among the top three in Nephrology and top ten in Critical care, pioneering in bringing novel molecules / formulations in Renal Care & Critical care. With more than 1500 distribution points, Alniche covers 30,000 hospitals both in Private /Corporate and Institutional sector. The most appreciable part of Alniche success is the respect that they enjoy from their key customers i.e. doctors, without their continuous support, Alniche would have not attained its growth path. Innovative formulations is one of the major success factor, as Alniche is pioneer in launching Ketoalfa sachet- aimed at improving patient compliance, Auxisoda and Auxisoda DS – enteric coated tablets and Fosfomycin injection. For chronic kidney disease, Alniche has introduced medicines for all the five stages, from pre-dialysis to post transplant stage.

In the Quest of Serving the Clients Better

Quality is the paramount importance for Alniche, hence all the manufacturers are certified with ISO, WHOGMP, and c-GMP certifications. Each product undergoes stringent testing during the manufacturing process, leaving no room for quality grievance. Alniche has its own Medical and Pharmacovigilance department that is engaged in PMS and coordination with manufacturers to ensure quality compliance. For a Life Sciences organization, R&D is a fundamental aspect. Alniche has a dedicated R&D unit backed by experts. The firm annually spends 10 percent of its profits on formulation development. Their key objective is to develop effective formulations for patients, thus contributing towards creation of a healthier India and a healthier world.

Like every new venture, there was a fair share of ups and downs along the way and quite many learning experiences; success was ensured on the back of strong fundamentals, clear vision, patient-centric approach, hand-picked portfolio, and above all a dedicated team. A young team of board of Directors (Ritu Hasija, Sumit Arora, Mehek Arora and Karan Arora) has been the pillar of strength who has been successfully chairing their independent responsibilities for collective achievement of organizational goal. The board is well supported by a strong and proficient senior leadership team of Jayan C.P., Mumtaz Siddique, Praveen Gautam, Pravin Naik, and Bishwa Sahoo. They have remained with the organization in all thick and thin, their loyalty and dedication being the driving force for Alniche’s sales and marketing teams. Implementing Right marketing strategy for Right set of portfolios with Right target audience is the focus for Alniche. A well-designed scientific marketing strategy to repetitively engage with the doctors keeps the company ahead of competitors. This involves various programmes like organizing CMEs, Symposia, Web hosting, Tele-consultations, Disease info & management, Advocacy development, News rooms, Latest in Therapeutic regimen- Book Release, Practice support & decision enhancement tools & few others. Each therapy is promoted by different team thus bringing required Positioning Focus with minimal overlap.

Alniche is committed to making available innovative pharmaceutical products in the Indian market in their pursuit to support medical fraternity in making patients’ lives healthier. They strive to cover entire spectrum of therapy from preventive, curative & maintenance aspects. Additionally, the firm is ready to mark its presence in the complementary market of medical devices and consumables in the selected therapy areas that align well with their pharma range and one such initiative of the firm is an entry into the advanced wound care segment.

Alniche continuously looks for opportunities to partner with global pharma companies as they firmly believe that strategic focus and a differentiated approach empower the organization. To strengthen new speciality divisions for addressing the therapy gaps, in-licensing of novel products in future growth areas is a critical piece of the overall strategy of the company. With this philosophy to the portfolio enrichment, Alniche has partnered with global pharma organizations to bring novel global brands in India from various companies including J W Life Sciences (Korea), Adhezion Biomedical Inc. (USA), FzioMed (USA), Advancis Medical (UK), PT Dermozone Pratama (Indonesia), Biovite (Australia), and Mastix (USA). In addition, the firm is also collaborating with various global companies that focus on therapy differentiation and ground breaking product concepts.

Recently, Alniche has formed an R&D alliance with Delhi Pharmaceutical Sciences & Research University (DPSRU) – India’s first Pharmacy University. This affiliation of industry and academia promises to augment further development of new products enabling innovations to meet the medical needs of Indian population. Additionally, as a part of their professional responsibility, Alniche has instituted awards to encourage the young researchers for the new research and innovative products and ideas. Alniche’s efforts have been recognised through various awards it has been receiving, including the Fastest growing brands & Leadership Award by Asia Once, Healthcare Elite Award by Business APAC and Businessman of the Year by Business Sphere.

The firm with a positive outlook aspires to build strong portfolio by in-licensing global brands and novel domestic products in the years to come. The company also aims to Strengthen speciality focus in marketing activities and to Improve operational efficiencies to ensure better ROI. As Alniche takes new strides into expanded presence in the Indian market, they continue to live the company philosophy of “Inspired By Value, Driven By Vision” and spreading Smiles and Wellness!

Exit mobile version